CSTL vs LNC · rev $187.2M vs P/E 4.9, rev $9.85B
Castle Biosciences Inc (CSTL) versus Lincoln National Corporation (LNC) — a side-by-side from cached financials, not a winner call.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Lincoln National Corporation (LNC) is a insurance - life company listed on US.
Latest reported CSTL revenue for 2026-06-30 was $187.2M. Net income was -$16.6M. CSTL currently screens at market cap $570.2M.
Latest reported LNC revenue for 2026-06-30 was $9.85B. Net income was $1.16B. Revenue was up 85.6% from 2026-03-31 to 2026-06-30. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
CSTL currently screens at market cap $570.2M. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
Not investment advice. Open the CSTL and LNC stock pages for the full models.
Not investment advice.